163 related articles for article (PubMed ID: 35346285)
1. Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis.
Lan K; Chen J
Radiat Oncol; 2022 Mar; 17(1):61. PubMed ID: 35346285
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis.
Zhao K; Si Y; Sun L; Meng X; Yu J
Radiat Oncol; 2020 Oct; 15(1):243. PubMed ID: 33087143
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
[TBL] [Abstract][Full Text] [Related]
5. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
6. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial.
Li J; Zhao Z; Du G; Dai T; Zhen X; Cai H; Liao D; Xiang M; Wen Y; Geng L; Yang X; Feng G; Zhang Y; Bai J; Liu L; Du X
Medicine (Baltimore); 2019 Jun; 98(26):e16176. PubMed ID: 31261551
[TBL] [Abstract][Full Text] [Related]
8. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
Liu T; Ding S; Dang J; Wang H; Chen J; Li G
Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
Lin CY; Fang HY; Lein MY; Lin CC; Bai LY; Tsai MH; Chen CC; Hsieh TC; Wang YC; Liang JA; Li CC; Chien CR
Anticancer Res; 2020 Apr; 40(4):2387-2392. PubMed ID: 32234942
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
11. Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study.
Chen B; Li Q; Li Q; Qiu B; Xi M; Liu M; Hu Y; Zhu Y
Oncologist; 2020 Apr; 25(4):308-e625. PubMed ID: 31880371
[TBL] [Abstract][Full Text] [Related]
12. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
[TBL] [Abstract][Full Text] [Related]
13. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.
Lin HN; Chen LQ; Shang QX; Yuan Y; Yang YS
Int J Surg; 2020 Aug; 80():184-191. PubMed ID: 32659390
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Zhang F; Wang Y; Wang ZQ; Sun P; Wang DS; Jiang YX; Zhang DS; Wang FH; Xu RH; Li YH
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868295
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.
Jingu K; Niibe Y; Yamashita H; Katsui K; Matsumoto T; Nishina T; Terahara A
Radiat Oncol; 2017 Sep; 12(1):146. PubMed ID: 28870211
[TBL] [Abstract][Full Text] [Related]
17. A retrospective evaluation of radiotherapy for the treatment of local esophageal squamous cell carcinoma recurrence after initial complete surgical resection.
Zhu YL; Li Q; Gao JM; Li JS; He ZY; Xu JJ; Lu XJ; Liu YM
J Investig Med; 2013 Jan; 61(1):34-9. PubMed ID: 23160184
[TBL] [Abstract][Full Text] [Related]
18. Salvage radiotherapy for postoperative locoregional failure in esophageal cancer: a systematic review and meta-analysis.
Mummudi N; Jiwnani S; Niyogi D; Srinivasan S; Ghosh-Laskar S; Tibdewal A; Rane P; Karimundackal G; Pramesh CS; Agarwal JP
Dis Esophagus; 2022 Mar; 35(3):. PubMed ID: 33912933
[TBL] [Abstract][Full Text] [Related]
19. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]